Please assess the completion status of the following clinical trial:

Trial Title: EpiCeram for Skin Protection in Healthcare Workers

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. HCW using PPE at least 6 hours/day, 4 days/week or, depending on shift work, 24 hours/week, for at least one (1) month~2. Men or women, any age~3. Overall skin irritation score of at least 4 on 0-10 scale where 0 = none and 10 = worst~4. Willing to stop use of any other emollient and lotion for one (1) week between screening and baseline visit and for the duration of the study.~5. Participant is willing to stop use of or not begin use of any topical corticosteroids, emollients and lotions to the hands and face for the duration of the trial.~Exclusion Criteria:~1. History of any skin disorder existing prior to March 1, 2020 characterized by chronic visible lesions or skin irritation symptoms including, but not limited to atopic dermatitis, eczema, moderate-severe acne, chronic dry skin and psoriasis.~2. Use of topical corticosteroids within one (1) month of baseline visit.~3. History of any significant medical condition that, in the opinion of the investigator, might put the subject at risk in this trial.~4. Participation in another clinical trial within 30 days or 5 half-lives of the study agent, whichever is longer.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- EpiCeram (Type: EXPERIMENTAL): Open-Label, 3 (three) times per day, topical, to hands and face, for 28 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).